An institute focusing on the development of new effective treatments for Alzheimer’s Disease has been established by the Keck School of Medicine of USC.
The USC Alzheimer’s Therapeutic Research Institute (USC ATRI) in San Diego will be led by a distinguished … Read More »
By Shelby Roberts
Alzheimer’s disease is the No. 6 cause of death in the United States, and stroke is the No. 4 cause.
Helena Chui, MD, chair, Department of Neurology, Raymond and Betty McCarron Chair in Neurology, and professor of neurology and gerontology at the Keck School of Medicine of USC, recently gave a presentation on Alzheimer’s disease and its relation to stroke on Nov. 6 as the sixth lecture in an ongoing Stroke Seminar Series at the Rio Hando Community Center in Downey, Calif. The event was hosted by the Roxanna Todd Hodges Stroke Foundation. … Read More »
Zlokovic named holder of newly endowed chair; brings total Zilkha giving to $30M
By Alison Trinidad
Los Angeles residents Selim Zilkha and Mary Hayley are raising the stakes in the fight against Alzheimer’s disease, the only cause of death among the top 10 in the United States that cannot currently be prevented, cured or slowed.
Zilkha, a member of the Keck School of Medicine of USC Board of Overseers, has pledged a gift of $5 million to the school to fund a new endowed chair in Alzheimer’s disease research. This latest gift brings Zilkha’s total giving to neuroscience research at the Keck School to more than $30 million. … Read More »
By Christine Chan and Amy E. Hamaker
Alzheimer’s disease is the sixth leading cause of death in the United States, and more than five million Americans live with the disease, according to the Alzheimer’s Association. Conquering Alzheimer’s was the focus of the first Zilkha Mini Symposium on Alzheimer’s Research at USC.
The symposium, held on Aug. 26 in honor of a visit by the Alzheimer’s Association’s Maria Carrillo, PhD, and Susan Galeas, MSW, MPH, covered a variety of topics, including brain imaging and mapping, genomics, the blood-brain barrier, new therapeutics for Alzheimer’s disease and an overview of clinical research at USC. … Read More »
By Kukla Vera
USC Professors Roberta Diaz Brinton, PhD, of the USC School of Pharmacy and Lon Schneider, MD, MS, of the Keck School of Medicine of USC are principal investigators of a newly funded study from the National Institutes of Health, aimed at testing promising drugs for the prevention of Alzheimer’s disease.
The USC project, “Allopregnanolone Regenerative Therapeutic for MCI/Alzheimer’s: Dose Finding Phase 1,” is the first clinical trial to evaluate the safety and tolerability of using allopregnanolone (Allo), a natural brain steroid, in treating mild cognitive impairment and Alzheimer’s disease, as part of an intensified national effort to find effective interventions for the degenerative brain disease. … Read More »